Infect Chemother.  2011 Oct;43(5):429-431. 10.3947/ic.2011.43.5.429.

Two Cases of Streptococcal Toxic Shock Syndrome Caused by Streptococcus agalactiae and Streptococcus dysagalactiae

• Suh YS
• Cheon YH
• Kim MK
• Ahn JH
• Lee SS
• Lim MH
• Kim BH
• Kim S
• Cho MJ
• Bae IG

• KMID: 2285018
• DOI: http://doi.org/10.3947/ic.2011.43.5.429

Abstract

Streptococcal toxic shock syndrome (STSS) is an acute, progressive illness that manifests with fever, hypotension, and accelerated multi-organ failure. It is usually caused by Group A Streptococcus (Streptococcus pyogenes). STSS due to non-group A streptococci is rare, but its incidence has recently increased. We report here on two cases of STSS caused by Group B Streptococcus (Streptococcus agalactiae) and Group G Streptococcus (Streptococcus dysagalactiae).

Keyword

Toxic Shock Syndrome; Streptococcus agalactiae; Streptococcus dysagalactiae

MeSH Terms

Fever
Hypotension
Incidence
Shock, Septic
Streptococcus
Streptococcus agalactiae

Reference

1. Cone LA, Woodard DR, Schlievert PM, Tomory GS. Clinical and bacteriologic observations of a toxic shock-like syndrome due to Streptococcus pyogenes. N Engl J Med. 1987. 317:146–149.

2. Tang WM, Ho PL, Yau WP, Wong JW, Yip DK. Report of 2 fatal cases of adult necrotizing fasciitis and toxic shock syndrome caused by Streptococcus agalactiae. Clin Infect Dis. 2000. 31:E15–E17.

3. Reich HL, Crawford GH, Pelle MT, James WD. Group B streptococcal toxic shock-like syndrome. Arch Dermatol. 2004. 140:163–166.

4. Wagner JG, Schlievert PM, Assimacopoulos AP, Stoehr JA, Carson PJ, Komadina K. Acute group G streptococcal myositis associated with streptococcal toxic shock syndrome: case report and review. Clin Infect Dis. 1996. 23:1159–1161.

5. Lee S, Yun NR, Kim KH, Jeon JH, Kang YM, Kim G, Park SW, Kim HB, Kim NJ, Oh MD. A case of group G streptococcal toxic shock syndrome. Infect Chemother. 2010. 42:187–189.

6. Horii T, Izumida S, Takeuchi K, Tada T, Ishikawa J, Tsuboi K. Acute peritonitis and salpingitis associated with streptococcal toxic shock syndrome caused by Lancefield group G alpha-haemolytic Streptococcus dysgalactiae subsp. equisimilis. J Med Microbiol. 2006. 55:953–956.

7. Schuchat A. Group B streptococcus. Lancet. 1999. 353:51–56.

8. Gaviria JM, Bisno AL. Stevens DL, Kaplan EL, editors. Group C and G streptococci. Streptococcal infections: clinical aspects, microbiology, and molecular biology. 2000. New York: Oxford University Press;180–221.

9. Lappin E, Ferguson AJ. Gram-positive toxic shock syndromes. Lancet Infect Dis. 2009. 9:281–290.

10. Shin JW, Son JW, Jung JW, Lee YW, Kim SW, Kim JY, Kim MK, Park IW, Park HM, Ryu WS, Choi BW. Streptococcal toxic shock syndrome secondary to salpingitis and panperitonitis in a previously healthy nongravid woman. Infect Chemother. 2005. 37:55–59.

11. Cho JK, Chung MH, Lee KH, Jo YC, Kim EC. A case of streptococcal toxic shock syndrome with myonecrosis. Korean J Infect Dis. 2000. 32:456–461.

12. Müller-Alouf H, Carnoy C, Simonet M, Alouf JE. Superantigen bacterial toxins: state of the art. Toxicon. 2001. 39:1691–1701.

13. Brandt CM, Spellerberg B. Human infections due to streptococcus dysgalactiae subspecies equisimilis. Clin Infect Dis. 2009. 49:766–772.

14. Tan JS, File TM. Yu VL, Weber R, Raoult D, editors. Streptococcus species. Antimicrobial therapy and vaccines. 2002. 2nd ed. New York: Apple tree productions, LLC;736.

15. Mascini EM, Jansze M, Schouls LM, Verhoef J, Van Dijk H. Penicillin and clindamycin differentially inhibit the production of pyrogenic exotoxins A and B by group A streptococci. Int J Antimicrob Agents. 2001. 18:395–398.